These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 16724166

  • 1. In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers.
    Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Volkert WA, Forte LR.
    Breast Cancer Res Treat; 2006 Jul; 98(1):7-15. PubMed ID: 16724166
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties.
    Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Forte LR, Volkert WA.
    Bioconjug Chem; 2004 Jul; 15(4):872-80. PubMed ID: 15264876
    [Abstract] [Full Text] [Related]

  • 3. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ, Murphy LC, Vrhovsek E, Sutherland RL, Lazarus L.
    Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
    [Abstract] [Full Text] [Related]

  • 4. Selective targeting of E. coli heat-stable enterotoxin analogs to human colon cancer cells.
    Giblin MF, Sieckman GL, Watkinson LD, Daibes-Figueroa S, Hoffman TJ, Forte LR, Volkert WA.
    Anticancer Res; 2006 May; 26(5A):3243-51. PubMed ID: 17094436
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
    Giblin MF, Sieckman GL, Shelton TD, Hoffman TJ, Forte LR, Volkert WA.
    Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
    [Abstract] [Full Text] [Related]

  • 6. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
    Reilly RM, Kiarash R, Cameron RG, Porlier N, Sandhu J, Hill RP, Vallis K, Hendler A, Gariépy J.
    J Nucl Med; 2000 Mar; 41(3):429-38. PubMed ID: 10716315
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
    Fitzpatrick SL, LaChance MP, Schultz GS.
    Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647
    [Abstract] [Full Text] [Related]

  • 9. Chemical synthesis of Escherichia coli ST(h) analogues by regioselective disulfide bond formation: biological evaluation of an (111)In-DOTA-Phe(19)-ST(h) analogue for specific targeting of human colon cancers.
    Gali H, Sieckman GL, Hoffman TJ, Owen NK, Mazuru DG, Forte LR, Volkert WA.
    Bioconjug Chem; 2002 Aug; 13(2):224-31. PubMed ID: 11906259
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [FGFB binding sites in cancers of the human breast].
    Peyrat JP, Hondermarck H, Hecquet B, Adenis A, Bonneterre J.
    Bull Cancer; 1992 Aug; 79(3):251-60. PubMed ID: 1392164
    [Abstract] [Full Text] [Related]

  • 17. Uroguanylin inhibits proliferation of pancreatic cancer cells.
    Kloeters O, Friess H, Giese N, Buechler MW, Cetin Y, Kulaksiz H.
    Scand J Gastroenterol; 2008 Aug; 43(4):447-55. PubMed ID: 18365910
    [Abstract] [Full Text] [Related]

  • 18. Heparin/heparan sulfate interacting protein expression and functions in human breast cancer cells and normal breast epithelia.
    Jacobs AL, Julian J, Sahin AA, Carson DD.
    Cancer Res; 1997 Nov 15; 57(22):5148-54. PubMed ID: 9371517
    [Abstract] [Full Text] [Related]

  • 19. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A, Schulz H, Emons G, Gründker C.
    Gynecol Endocrinol; 2008 Jun 15; 24(6):331-8. PubMed ID: 18584413
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of (111)In-labeled triplex-forming oligonucleotide targeting human N-myc gene.
    Cho JG, Kim MK, Oh EJ, Yoon EJ, Sohn J, Park MK, Park GH.
    Mol Cells; 2002 Aug 31; 14(1):93-100. PubMed ID: 12243359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.